The dual Ser/Thr kinase MKK4 and its downstream targets JNK and p38 regulate critical cellular functions during embryogenesis and development. MKK4 has been identified as a putative tumor-suppressor gene in human solid tumors of breast, prostate and pancreas. To clarify the mechanisms underlying the transforming potential of molecular defects targeting MKK4, we have generated totipotent embryonic stem (ES) cells expressing the dominant-negative mutant DN-MKK4 Ala , S257A/ T261A. Stably transfected DN-MKK4-ES cells exhibit a transformed fibroblast-like morphology, reduced proliferation rate, were no more submitted to cell contact inhibition, were growing in soft agar, and were much more tumorigenic than parental ES cells in athymic nude mice. These phenotypic changes: (i) are consistent with the protection of DN-MKK4-transfected ES cells from spontaneous, cell density-dependent, and stress-induced apoptosis (DAPI staining and poly (ADP-ribose) polymerase (PARP) cleavage) and (ii) correlated with alterations in JNK, p38, and Erk-1/-2 MAPK/SAPK signaling. Taken together, our data provide a new mechanism linking the MKK4 signaling pathways to cancer progression and identify MKK4 as a tumorsuppressor gene implicated in several transforming functions.
Introduction
Mitogen-activated protein kinases (MAP kinase, MAPK hereafter) encompass three distinct families of closely related serine/threonine protein kinases, namely extracellular signal-regulated kinase (ERK) and stressactivated protein kinases (SAPK) p38 MAPK and c-jun NH2-terminal kinase. MAPK and SAPK regulate a variety of developmental processes and are involved in cellular responses to environmental cues (Marshall, 1995; Su and Karin, 1996; Treisman, 1996; Whitmarsh and Davis, 1996) . Such a pivotal role stands especially true for the MEKK1/MAPKKK1, SEK1/MKK4/ JNKK, and SAPK/JNK cascades. Indeed, MKK4 and the JNK/p38 signalling cascades are triggered by environmental stress, tumor promoters (e.g. heat, excitotoxic and osmotic shocks, UV irradiation, DNA damage, phorbol esters, bile acids), growth factors and inflammatory cytokines (e.g. EGF/TGF-a, TGF-b, TNF-a, and IL-1) (Atfi et al., 1997; Ganiatsas et al., 1998; Roulston et al., 1998) . For example, TGF-b was first reported to induce the morphologic transformation of rat kidney fibroblasts and to exert cell type-specific effects as inhibitor or activator of cell proliferation and transformation, depending upon the oncogenic status of the cell (Sporn et al., 1986; Ferrigno et al., 2002; Prunier et al., 2003) . Both MKK4 and JNK upregulate AP-1 transcriptional activity involved in the regulation of cancer progression by tumor promoters and oncogenes (Whitmarsh and Davis, 1996; Ganiatsas et al., 1998; Rivat et al., 2003; Young et al., 2003) .
MKK4-regulated JNK activation also plays a critical role during embryogenesis (e.g. in morphogenesis and organogenesis) (Hilberg et al., 1993; Ganiatsas et al., 1998; Lee et al., 1999; Nishina et al., 1999) and postnatal development, as it is the case for Drosophila homologues hemipterous and basket (Glise et al., 1995) . In mammals, this was suggested by dynamic changes in MKK4 expression in the liver, thymus, and brain during embryogenesis (Nishina et al., 1997; Lee et al., 1999) , and was confirmed in the homozygous MKK4
À/À mice. These MKK4 À KO mice display altered hepatogenesis and die early in the course of embryonic development, between days 10.5 and 12.5, exactly as do the c-jun À/À mice (Hilberg et al., 1993; Nishina et al., 1997 Nishina et al., , 1999 Ganiatsas et al., 1998) . Moreover, MKK4 has been suspected to function as a tumor-suppressor gene. Biallelic inactivation of the MKK4 gene (i.e. combined expression of somatically acquired sequence variants devoid of kinase activity with LOH) was identified in cancers of the breast, colon, testis, and pancreas (Teng et al., 1997; Su et al., 1998) . The finding by Su et al. (1998) of a somatic missense mutation in the MKK4 gene in the absence of any other nucleotide polymorphisms or silent nucleotide changes further supports MKK4 as a mutationally targeted tumor-suppressor gene. Concomitant mutations of other tumor-suppressor genes in MKK4-deficient tumors suggest that MKK4 may participate in signaling networks involved in tumor suppression (Su et al., 1998) .
To further examine the tumor-suppressor potential of the dual Ser/Thr kinase MKK4 and of its downstream targets JNK and p38, we have engineered mouse embryonic stem (ES) cells AB-1 (designated as ES cells hereafter - Evans and Kaufman, 1981; Martin, 1981; Beddington and Robertson, 1989; Ramirez-Solis et al., 1993) , expressing a dominant-negative mutant of MKK4 in a constitutive manner (DN-MKK4 hereafter - Whitmarsh et al., 1995) . The totipotent ES cell lines support a normal embryonic and postnatal development and harbor a diploid karyotype. This model allowed us to investigate the tumor-suppressor role of MKK4 in tumorigenic cells under a molecular and cellular context devoid of generalized genomic instability, chromosome aberrations, loss of tumor-suppressor genes and activating oncogenic mutations. Such common alterations are inherent to the multistage progression of solid tumors and might circumvent the MMK4 blockade in fully transformed cells, such as epithelial cancer cell lines established from sporadic tumors (Markowitz et al., 2002) . In contrast, only limited chromosomal changes were observed in long term cultures of mouse and human ES cells (Draper et al., 2004) . Finally, ES cell growth and differentiation are controlled by a vast array of genes and molecular signals that influence cellular functions involved in normal and neoplastic development, including cell proliferation and survival (Nakano, 1995; Okabe et al., 1996; Wobus et al., 1997) . ES cells are thus appropriate to analyse the impact of the MMK4 signaling pathways on cell differentiation and neoplastic progression.
The present study shows that disruption of MKK4 signaling in AB-1 ES cells transfected by the dominantinterfering mutant S257A/T261A induces several morphological and functional alterations associated with the neoplastic progression, including fibroblast-like morphology, growth in soft agar, increased survival, loss of contact inhibition in vitro, and enhanced tumor growth in nude mice. Taken together, our data indicate that disruption of MKK4 signaling by inactivating mutations and bi-allelic loss can play a critical role in neoplastic progression, and identify MKK4 as a tumor-suppressor gene involved in the progression of several human solid tumors.
Results

Expression of DN-MKK4 in ES cells leads to morphological transformation
To check whether MKK4 signaling was of key importance in ES cell differentiation, proliferation, and transformation, mouse AB-1 ES cells were transfected with either DN-MKK4 (Whitmarsh et al., 1995) or the cognate control vector (pcDNA3), then G418-resistant colonies were selected and cloned.
Ectopic expression of the DN-MKK4 mutant in ES cells was analysed by immunoblotting. A band corresponding to the DN-MKK4 mutant harboring a Flag epitope was identified only in Cl.2 and Cl.8 ES cells (Figure 1a) . In contrast, a bona fide MKK4 band (44 kDa) was observed in cell extract prepared from either control, pcDNA3-, and DN-MKK4-transfected ES cells when the blots were probed with an anti-MKK4 monoclonal antibody (Figure 1b) . The intensity of the MKK4 band was identical in ES, pcDNA3-transfected ES, Cl.2, and Cl.8 cells, supporting the conclusion that the overall amount of MKK4 protein was not increased in DN-MKK4-transfected ES cells.
Control, wild-type ES cells were small and grew as small, tightly packed nests, in which it was difficult to discern individual cells (black arrowhead in Figure 1c ). This phenotype was not altered in pcDNA3-transfected ES cells grown in selection medium (Figure 1d ). When cultured for several days without splitting, the nests of wild-type and pcDNA3-transfected ES cells increased in size, merged to form a confluent layer, then single cells detached from the substratum and died (vide infra). Interestingly, DN-MKK4-transfected ES cells cultured for 10 days in selection medium appeared as fibroblastlike cells (elongated, spindle-shaped) and spread over the surface of the Petri dish (Figure 1e ). The phenotype of DN-MKK4-transfected ES cells was stable over time even in single-cell-derived clones maintained in culture for several weeks by repeated subculture (Cl.2 and Cl.8, Figures 1f and g ). Interestingly, in long-term cultures of Cl.2 and Cl.8 cells, no contact inhibition of cell proliferation was observed at confluency, leading to the superimposition of multiple layers of cells, and to the formation of foci 15-18 days after plating (black arrowhead in Figure 1h ). Moreover, Cl.2 and Cl.8 cells seeded in low melting agarose gave rise to numerous colonies after 14 days, in contrast to wild-type or pcDNA3-transfected ES cells (Table 1) . Such an anchorage-independent proliferation in soft agar supports the conclusion that suppression of MKK4 activity induces ES cell transformation.
Expression of DN-MKK4 enhances the tumorigenicity of ES cells in nude mice
Injection of wild-type ES cells into nude mice yielded tumors (Evans and Kaufman, 1981; Martin, 1981) , with nodules that exceeded 4 mm in diameter being observed after a 9-10 days lag in tumor take (Figure 2 ). The mean size of the nodules increased fivefold between days 10 and 15. Interestingly, when Cl.2 and Cl.8 cells were injected into nude mice, the tumors appeared earlier (6-7 days post-injection) and were 4.6 times larger than in mice that had been injected with wild-type ES cells (Figure 2 ). These data support the notion that disruption of MKK4 signaling exacerbates the tumorigenicity of ES cells.
The proliferation rate is slowed down in DN-MKK4-transfected ES cells When seeded at low density (31 Â 10 3 cells/cm 2 ), wildtype ES cells grew exponentially between the onset of the culture and day 4, when they began to detach from the substratum and die. Their mean doubling time was about 24 h (Table 2) . Identical results were obtained with pcDNA3-transfected ES cells (not shown). In contrast, Cl.2 and Cl.8 cells exhibited B2-fold increased generation times when cultured under the same conditions (Table 2) . Accordingly, Cl.2 and Cl.8 cells exhibited a slower rate of 3 H-thymidine incorporation into DNA than wild-type ES cells and the magnitude of the decrease (56 and 40%, respectively) was sufficient to account for their increased doubling time (Table 2) .
Apoptosis is inhibited in DN-MKK4-transfected ES cells
Wild-type ES and pcDNA3-transfected, as well as Cl.2 and Cl.8, cells were collected at high density 8 days postseeding, and stained with DAPI. At the time of harvest, most wild-type and pcDNA3-transfected ES cells were floating, gathered as small clumps. More than 95% of (h) The DN-MKK4 Cl.2 clone was seeded as in (f), and cultured for 15 days (magnification: Â 100, scale bar in (c-h) ¼ 80 mm). Note that wild-type (c) and pcDNA-3-transfected (d) ES cells displayed similar morphology, and grew as small, tightly packed nests in which it is difficult to discern individual cells (black arrowhead), whereas DN-MKK4-transfected ES cells appeared as individual, elongated, and spindle-shaped cells (e-g). When DN-MKK4 clones were grown for several days without any splitting (h), superimposition of multiple cell layers and the formation of foci (black arrowhead) were observed, suggesting the loss of contact inhibition of cell proliferation Tumor-suppressor functions of MKK4 in ES cells M Cazillis et al the cell population appeared with a rounded, highly fluorescent nucleus surrounded with a shrunken cytoplasmic ring, a figure that is characteristic of apoptotic cells (Figure 3a and b). In contrast, more than 95% of Cl.2 and Cl.8 cells were still adherent to the substratum at day 8 and displayed a diffuse pattern of DAPI fluorescence, pointing out that they had not entered the apoptotic process (Figure 3c and d).
Cell survival in DN-MKK4-transfected ES cells was also assessed by studying poly (ADP-ribose) polymerase (PARP) cleavage. Only a small fraction of PARP (11.3% of total PARP immunoreactivity) was cleaved in wild-type ES cells grown at low density (1 day after plating). PARP cleavage remarkably increased 3.7-fold as ES cells grew to confluency at day 4 ( Figure 3e , upper panel). Similarly, the fraction of cleaved PARP increased from 10 to 29% as a function of cell density in pcDNA3-transfected ES cells, between days 2 and 4 ( Figure 3e , upper panel). In contrast, the fraction of cleaved PARP remained low and constant (17% of total PARP immunoreactivity) in sparse and confluent Cl.2 and Cl.8 cells, even when cells grew as superimposed layers, at day 15 and later ( Figure 3e , middle and lower panels). Treatment with anisomycin did not increase the extent of PARP cleavage in wild-type, pcDNA3-, and DN-MKK4-transfected ES cells (Figure 3f ), suggesting that this chemical stress was ineffective in triggering the apoptosis of ES cells, whatever the status of MKK4 activity. Our data support the conclusion: (i) that suppression of MKK4 activity protected mouse ES cells from constitutive apoptosis and (ii) that the slower rate of proliferation of Cl.2 and Cl.8 cells was not due to increased cell death.
Alterations in JNK, p38 MAPK, and Erk-1/-2 signaling in DN-MKK4-transfected ES cells
We analysed the phosphorylation and activation status of JNK, using a polyclonal antibody which reacts specifically with the phosphorylated form of JNK but not with the phosphorylated forms of Erk-1/-2 or p38 MAP/SAP kinases. In sparse cultures of ES cells (Sp), two faint bands were stained by Western blot (Figure 4a ). One band corresponded to a weak phosphorylation of the p46 JNK isoform on Thr 183 / Tyr 185 , the other band was nonspecific (Figure 4a , upper panel). In contrast, both p46 and p54 JNK isoforms were stained by the anti-phospho-JNK antibody in high-density (Co) cultures of ES cells (Figure 4a , upper panel). Similar results were obtained with pcDNA3-transfected cells (Figure 4a ). In both cases, the increase in JNK phosphorylation mirrored an actual kinase activation in high-density cultures rather than an overall increase in JNK expression, since the levels of JNK proteins were identical in cells collected either from sparse and high-density cultures (Figure 4a , lower panel). In contrast, faintly stained bands of phosphorylated p46 and p54 JNK isoforms were always observed in clones Cl.2 and Cl.8 cells, whatever the lag (2 or 7 days) between seeding and the phosphorylation study (Figure 4a, . Accordingly, JNK activity was undetectable using an immune complex kinase assay in Cl.2 and Cl.8, but was significant in ES cells (Figure 4b ) and pcDNA3-transfected ES cells (not shown). Such a low JNK phosphorylation level and activity in Cl.2 and Cl.8 was not due to downregulation of JNK expression in DN-MKK4-transfected cells, since the overall amount of JNK was similar in all cell types considered ( Figure 4a, lower panel) . Thus, the dominant-interfering mutant of MKK4 efficiently obliterates endogenous MKK4 activity in DN-MKK4-transfected ES cells. In addition, our observation that the level of JNK phosphorylation was dependent on cell density in ES and pcDNA3-transfected ES cells suggests that JNK activity might be dependent on cellular adhesion with the extracellular matrix (ECM) and/or cell-cell contacts.
Since p38 MAPK is also activated through MKK4 signaling, we have investigated its phosphorylation status in wild-type vs DN-MKK4-transfected ES cells. In sparse cultures of parental, pcDNA3-, and DN-MKK4-transfected ES cells (Cl.2 or Cl.8) at day 2 postseeding, no constitutive p38 phosphorylation was observed (Figure 4c , upper panel, and data not shown). Figure 5 ). In contrast, the p42/p44 Erk-1/-2 kinases were strongly phosphorylated on Thr 202 /Tyr 204 in Cl.2 and Cl.8 cells, suggesting constitutive Erk activation in DN-MKK4-transfected ES cells.
Discussion
MKK4
À/À ES cells have been engineered in several laboratories (Nishina et al., 1997; Ganiatsas et al., 1998) . Expression of this gene is required for embryonic viability, suggesting multiple roles during early developmental stages in mice Ganiatsas et al., 1998; Lee et al., 1999) . In the present work, we have explored the hypothesis that MKK4 might be involved in the regulation of ES cell proliferation, transformation, apoptosis, and neoplastic progression in vivo.
MKK4 has been described as a dual-specificity kinase that activates JNK and p38 MAP/SAP kinases (Lin et al., 1995) . As expected, expression of the dominantinterfering mutant of MKK4 in ES cells resulted in complete inhibition of JNK phosphorylation and 5 cells/well, and cultured for up to 9 days in DMEM-15. At the indicated time points after plating (quoted above the lanes), nuclear extracts were prepared, and PARP cleavage was assayed by Western blot. When indicated ( þ ), the cells were treated with 10 mg/ml anisomycin for 1 h prior to cell harvest. (a and e) Arrowheads point to the intact (116 kDa, p116) and cleaved (85 kDa, p85) forms of PARP Tumor-suppressor functions of MKK4 in ES cells M Cazillis et al activity. Since the total amount of wt and DN-MKK4 was similar in parental ES cells and the DN-MKK4 clones Cl.2 and Cl.8, our models minimize nonspecific interactions by excessive overexpression of DN-MKK4 vs endogenous MKK4 protein levels and other structurally related kinases. Specifically, inhibition of JNK activity through a direct DN-MKK4/JNK interaction seems unlikely (Kieran et al., 1999) . In addition to its inability to phosphorylate JNKs and p38 MAPKs by its own, DN-MKK4 encompasses MAPK docking D-sites in its N-terminus (Ho et al., 2003) . This D-site may be involved in high-affinity binding and sequestering JNKs and p38 MAPK in genetically modified DN-MKK4-ES cells, and thus prevent their phosphorylation by resident MKK4. This will contribute to strengthen the inhibitory effect of DN-MKK4 observed at low expression levels. Alternatively, one can postulate that high expression levels of DN-MKK4 over wild-type MKK4 are not compatible with ES cell integrity, as suggested in transgenic animal studies, showing that deletion of the MKK4 gene is associated with embryonic lethality. Accordingly, mice null for the p38a isoform die during embryonic development (Allen et al., 2000) .
Expression of DN-MKK4 blunted stress-induced p38 phosphorylation by anisomycin in our studies. The latter observation contrasts with the occurrence of stress-induced activation of p38 in MKK4 À/À ES cells (Ganiatsas et al., 1998) and suggests that MKK4 regulates another upstream activator of p38 (e.g. MKK3/6), in a JNK-independent manner. In contrast, these authors reported that MKK4 À/À mouse fibroblasts exhibit defects in stress-induced p38 phosphorylation (Ganiatsas et al., 1998) , exactly as do DN-MKK4-transfected ES cells that have acquired a transformed fibroblast-like phenotype in the present study, a recognized signature of the malignant transformation. Increased tumorigenicity of ES cells transformed by DN-MKK4 might be linked to the constitutive activation of Erk-1/Erk-2, acting as tumor growth promoters in vivo. Our data are consistent with the observation that dominant-active mutants of MEK1 induce rapid tumor formation in nude mice (Brunet et al., 1994) . As mentioned above, ES cells can give rise to many (ex vivo), or any differentiated cell types during embryonic development (Beddington and Robertson, 1989; Nakano, 1995; Okabe et al., 1996; Wobus et al., 1997) . Current work is in progress in our laboratory to investigate the impact of the MKK4 signaling defects on the differentiation programs controlled by ES cells ex vivo.
Ablation of MKK4 in MKK4
À/À ES cells results in a series of direct and indirect signaling defects. Some of these alterations, connected with a loss of the MKK4 protein are not achieved with the dominant-interfering MKK4 mutant, a competitor of the resident MKK4 protein for its signaling partners. Our model may thus help to uncover yet undefined regulatory circuits that depend on the presence of MKK4 as a scaffold signaling molecule functioning independently of its kinase activity, via protein-protein interactions. Indeed, deletions and nonsense or missense mutations were identified at the MKK4 locus in various human tumors (Teng et al., 1997; Su et al., 1998) . In the present study, confluent monolayers of DN-MKK4-transfected ES cells were no more submitted to contact inhibition since Cl.2 and Cl.8 grew as multiple layers, and even formed foci, another signature of the transformed phenotype. Accordingly, DN-MKK4-transfected ES cells are growing in an anchorage-independent manner and display enhanced tumor growth in athymic nude mice. Thus, disruption of MKK4 signaling and subsequent inhibition of the MKK4/JNK and/or MKK4/p38 MAPK pathways in ES cells trigger the acquisition of several cellular dysfunctions associated with cancer progression, supporting the tumor-suppressor role of MKK4, as suggested by Yoshida et al. (1999) and Yamada et al. (2002) .
Several mechanisms can be envisioned to account for the transformation potential of altered forms of MKK4. First, growing ES cells to confluency leads to increased detachment from the substratum and apoptosis. This anoikis correlates with increased JNK phosphorylation and activity. Accordingly, no such apoptosis was observed when JNK phosphorylation and activity were blunted in DN-MKK4-transfected ES cells. It seems unlikely that this apoptotic process is due to p38 activation. As a matter of fact, p38 is not constitutively phosphorylated 2 or 4 days after plating, although the extent of apoptosis is increased by 2.5-fold. Although anisomycin induces p38 phosphorylation, it does not trigger apoptosis of wild-type ES cells. These observations support the conclusion that p38 does not play a critical role in apoptosis in this context. Accordingly, Allen et al. (2000) reported that there is no significant difference between p38a þ / þ and p38a À/À ES cells in chemically induced apoptosis, suggesting that p38a is not a critical component in cell survival induced by this form of apoptosis. Since both sparse and confluent cultures of ES cells grew as tightly packed nests of cells, it seems unlikely that apoptosis was triggered by increased cell-cell contacts. Rather, the progressive loss of integrin-mediated cell-ECM interactions as ES cells reached confluency might be involved. It should be stressed that loss of matrix anchorage may activate a caspase that cleaves and activates MEKK1, an upstream kinase in the JNK pathway, and triggers apoptosis (Cardone et al. 1997) . The involvement of the MKK4/ JNK pathway in density-dependent apoptosis of wildtype ES cells is consistent with its role in triggering apoptosis in response to various stimuli, including stress, major histocompatibility complex ligation, and Fas (Wilson et al., 1996; Skov et al., 1997; Yang DD et al., 1997; Yang X et al., 1997) . JNK-mediated apoptosis has also been shown to be associated with a tight regulation of essential nuclear enzymes levels during the cell cycle (McPherson and Goldenberg, 1998 ). An alternative explanation may be that loosening the interactions between wild-type ES cells and the ECM upon confluency results in reduced G 1 cyclindependent kinase activity, and accumulation of hypophosphorylated retinoblastoma protein (pRb), which in turn triggers apoptosis (Day et al., 1997) . Second, the doubling time of DN-MKK4 ES cells is slowed down B2-fold, consistent with the B50% reduction in the rate of DNA replication. The lower proliferation potential observed in DN-MKK4-transfected ES cells resulted from an increased duration of the G 1 and G2 phases of the cell cycle (respectively, 2.4670.31-and 1.5870.3-fold), while the S phase remained unchanged (1.0870.12-fold). Accordingly, MKK4
À/À primary mouse embryo fibroblasts (MEFs) grow more slowly than wild-type MEFs (Ganiatsas et al., 1998) . Moreover, Behrens et al. (1999) showed that MEFs homozygous for a mutant, nonphosphorylatable allele of c-Jun (with Ser 63 and Ser 73 mutated to Ala, JunAA) exhibit a slower proliferation rate than wild-type MEFs. Alternatively, we may speculate that the constitutive activation of Erk-1/Erk-2 in DN-MKK4-transfected ES cells contributes to their slow rate of proliferation in vitro. Indeed, the growth rate of ES cells was enhanced in wild-type undifferentiated ES cells treated with a specific MEK1 inhibitor (Skov et al., 1997; Burdon et al., 1999) . Accordingly, Erk activation is fully dispensable for the regulation of cyclin D 1 level and progression through the cell cycle G 1 -S transition in undifferentiated ES cells (Jirmanova et al., 2002) . Finally, constitutive Erk activation (e.g. due to the cross-talk between the Ras/Raf/Erk and other signaling cascades) has recently been reported to be involved in the inhibition of proliferation of several cell types in vitro (Moelling et al., 2002) . The mechanism involved in DN-MKK4-induced Erk-1 and -2 activation can be explained by the negative cross-talk played by activated JNK on Erk activation induced by growth factors (Shen et al., 2003) . According to this scenario, the JNK pathway inhibitor DN-MKK4 would obliterate such a repressive role and induce a constitutive Erk activation. Thus, while growth factors induce a rapid and transient Erk activation as a 'classical molecular signature of mitogenic responses', chronic Erk activation in our studies will be transduced as a growth-inhibitory signal in vitro, as shown in Table 2 . The decrease in the proliferation rates of DN-MKK4-transfected ES cells was not due to increased constitutive apoptosis, as estimated by DAPI staining, by PARP cleavage (Duriez and Shah, 1997) or by flow cytometry (not shown). Similarly, the slower proliferation rate of JunAA/JunAA MEFs was not linked to increased apotosis (Behrens et al., 1999) . DN-MKK4 ES cells do not stop growing with time in culture, in sharp contrast with what was observed with Jun À/À MEFs, which undergo one or two rounds of cell division ex vivo before growth stops in G 1 (Wisdom et al., 1999) . Altogether, these results suggest that in DN-MKK4 ES cells as well as in JunAA/JunAA MEFs, the lack of serine phosphorylation in the transactivation domain of c-Jun (Ser 63 , Ser 73 ) (i) might explain the slower rate of proliferation, and (ii) is not sufficient to trigger growth arrest in G 1 and senescence ex vivo.
Combining our data with previous studies showing the essential role of JNK, p38, and Erk-1/-2 in cell proliferation and apoptosis (Manning and Davis, 2003; Schultz, 2003) , we propose a model in which disruption of MKK4 signaling resulted in exacerbation of the neoplastic transformation and acquisition of multiple cellular dysfunctions that are observed at the early and late stages of the disease.
Materials and methods
Plasmids
The pcDNA3-Flag-MKK4 Ala (DN-MKK4 hereafter) corresponds to the S257A and T261A double point mutant of human MKK4 (Whitmarsh et al., 1995) . GST-Jun (1-79) was expressed in Escherichia coli, as outlined in Minden et al. (1994) .
Cell culture and transfection
Totipotent murine ES cells (AB-1, a generous gift from A Bradley) were cultured in Dulbecco's modified Eagle medium (DMEM; Life Technologies) containing 4.5 g/l glucose, and supplemented with 15% fetal calf serum (ATGC), 2 mM L-glutamine, non-essential amino acids, 50 mg/ml gentamycin, and 0.1 mM b-mercaptoethanol (DMEM-15). To avoid any differentiation of the ES cells in culture, they were grown on feeder layers of mitotically arrested STO cells (line SNL76/7) (Ware and Axelrad, 1972; Robertson, 1987) .
ES cells were trypsinized during the exponential growth phase, collected by centrifugation and resuspended in Ca 2 þ -and Mg 2 þ -free Dulbecco's phosphate buffered saline (PBS) at a density of 1.1 Â 10 7 cells/ml. Replicate 1 ml samples of cell suspension were electroporated with 25 mg of either pcDNA3 or DN-MKK4 (230 V/cm, 500 mF; Biorad Gene Pulser), and the cells were grown in DMEM-15 supplemented with 350 mg/ ml Geneticin (G418; Life Technologies). After 10-12 days G418-resistant colonies were isolated, pooled, and single cellderived clones were selected.
Nuclear extracts
Monolayers of wild-type or DNMKK4-transfected ES cells were scrapped with a rubber policeman, and the cells were collected by centrifugation at 500 g for 5 min (41C). The cell pellets were washed once with 1 ml of chilled PBS, then weighed. Crude nuclear extracts were prepared essentially as described in Andrews and Faller (1991), then stored frozen at À801C until use.
PARP cleavage assay
Replicate aliquots of nuclear extracts (equivalent to 2 mg of packed cells pellet) were subjected to SDS-PAGE (7% acrylamide) and electroblotted onto nitrocellulose membranes (BA83, Schleicher and Schuell). The membranes were first soaked in PBST (0.1% Tween-20 in PBS) supplemented with 5% non-fat dry milk (1 h at room temperature -RT). Thereafter, the blots were incubated at RT for 1 h with a 1 : 1000 dilution of mouse anti-PARP monoclonal antibody in PBST (clone C2-10; Pharmigen). After three washes with PBST, the membranes were incubated at RT for 1 h with a 1 : 1000 dilution of sheep anti-mouse IgG antibody coupled to horseradish peroxidase in PBST (NA931; Amersham). Immune complexes were revealed by chemiluminescence (ECL; Amersham), according to the manufacturer's instructions.
DAPI staining
Cells were seeded in six-well plates at a density of 3 Â 10 5 cells/ well, and cultured for up to 18 days in DMEM-10. At each time point, floating cells and adherent cells were mixed, collected by centrifugation, fixed in 70% ethanol, and permeabilized in PBST. After a 5 min staining with DAPI (0.6 mg/ml PBS), chromatin fluorescence was observed under a UV-light microscope.
Monitoring of cell proliferation
Cells were seeded in six-well plates at a density of 3 Â 10 5 cells/ well, and cultured for up to 7 days in DMEM-15. When the rate of DNA replication was to be measured, the cells were incubated for 4 h in the presence of 3 H-thymidine (1.5 mCi/ml in fresh DMEM) just prior to cell harvest. At each time point, the culture medium was removed from three independent wells, the cells were washed twice with chilled PBS, collected, then homogenized by sonication (3 Â 10 s; 41C) in 500 ml of 50 mM NaPO 4 , pH 7.4, 2 M NaCl, 2 mM EDTA. In all, 450 ml of the homogenates was decanted and 3 H-thymidine incorporation into DNA was quantified by liquid scintillation counting of trichloracetic acid-insoluble radioactivity, using a filter assay (Sambrook et al., 1989) . The DNA content of the homogenates was quantified by fluorescence spectrometry using Hoechst 33258 as a dye (Labarca and Paigen, 1980) .
Assay of tumorigenicity in nude mice
Cells (5 Â 10 6 ) were suspended in 0.2 ml of sterile PBS, and inoculated into the abdominal subcutaneous tissue of athymic nude mice. The growth of tumor xenografts was monitored twice weekly over a 6-week period, and was scored positive when the diameter of the nodule exceeded 4 mm (Rao et al., 1997) . Groups of mice were killed at 7, 10, and 15 days postinoculation. The nodules were collected at the time of killing, weighed, and their volumes were measured.
Jun kinase assay
JNK activity was assayed as described in Atfi et al. (1997) . Briefly, cells were lysed at 41C in 25 mM HEPES, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 1% Triton X-100, 0.5% sodium deoxycholate, 20 mM bglycerophosphate, 1 mM sodium vanadate, 1 mM PMSF, 20 mg/ ml aprotinin, 20 mg/ml leupeptin, and the lysates were cleared by centrifugation. Endogenous JNK was immunoprecipitated using an anti-JNK polyclonal antibody (Santa Cruz), and binding of the immune complexes to protein G sepharose beads. The beads were then washed extensively with lysis buffer, and resuspended in 30 ml of 12.5 mM MOPS, pH 7.5, 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM sodium vanadate, 0.5 mM sodium fluoride, 2 mg GSTJun, 5 mCi (g 32 P)-ATP, and 20 mM unlabeled ATP. The kinase assay was performed at 301C for 20 min, and the reaction products were analysed by SDS-PAGE and autoradiography.
Analysis of JNK and p38 MAPK phosphorylation
Cells were lysed and the homogenate was spun at 800 g for 4 min. Replicate aliquots of the post-nuclear supernatants (equivalent to 2 mg of packed cells pellet) were subjected to SDS-PAGE (7% acrylamide) and Western blot analysis (vide supra) was performed using a 1 : 1000 dilution of a rabbit antiphospho-SAPK/JNK polyclonal IgG (Thr 183 /Tyr 185 ; Santa Cruz), or of rabbit anti-SAPK/JNK, or of rabbit anti-p38 MAPK, or of rabbit anti-phospho-p38 MAPK (Cell Signaling), or anti-Flag-M2 (Sigma) as the primary antibody. A 1 : 5000 dilution of goat anti-rabbit IgG antibody coupled to horseradish peroxidase (goat F(ab 0 ) 2 ; Immunotech) was used as the secondary antibody. Immune complexes were revealed by chemiluminescence (ECL; Amersham), according to the manufacturer's instructions.
